Hemetron AG

Improving people’s health through at-home blood monitoring.

Hemetron is transforming chronic disease management with precise, at-home blood testing. Millions of patients with inflammatory rheumatic diseases lack effective monitoring, resulting in poor treatment adjustments. Our unique blood test enables patients to measure inflammation levels at home, empowering both patients and doctors to make timely, data-driven decisions. This innovation improves disease management, reduces healthcare costs, and addresses a critical need in chronic disease management and beyond.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2022

Website

Venture Leaders Medtech

Venture Leaders Medtech 2025

Hemetron AG

Improving people’s health through at-home blood monitoring.

Website:
www.hemetron.com

Headquarter:
Thalwil

Foundation Date:
October 2021

Technology:

  • Medtech

Sectors:

  • Digital Health
  • Diagnostics
  • Medical devices
  • Medtech
  • Patient monitoring

Support received

  • Support venture leaders
  • Support venturekick